Simon, Christopher Haemonetics Corp (HAE) insider trading activity

Simon, Christopher is President & CEO of HAEMONETICS CORP. Currently has a direct ownership of 375,544 shares of HAE, which is worth approximately $28.7 Million. The most recent transaction as insider was on May 16, 2022, when has been sold 26,041 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 376K

16.33% 3M change

3.59% 12M change

Total Value Held $28.7 Million

Simon, Christopher Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2022	BUY Grant, award, or other acquisition	-	26,041 Added 10.7%	217,368 Common Stock
Jun 14 2021	SELL Open market or private sale	$71,844 $59.87 p/Share	1,200 Reduced 0.62%	191,806 Common Stock
Jun 07 2021	SELL Open market or private sale	$149,569 $55.09 p/Share	2,715 Reduced 1.39%	193,006 Common Stock
May 19 2021	SELL Open market or private sale	$56,515 $55.19 p/Share	1,024 Reduced 0.52%	195,721 Common Stock
May 18 2021	BUY Grant, award, or other acquisition	-	26,515 Added 11.88%	196,745 Common Stock
May 17 2021	SELL Open market or private sale	$53,507 $55.97 p/Share	956 Reduced 0.56%	170,230 Common Stock
Dec 10 2020	SELL Bona fide gift	-	194,369 Reduced 53.21%	170,941 Common Stock

Also insider at

SHC

Sotera Health Co Healthcare